From: Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
Characteristic | Number (%) | Low expression | High expression | P value |
---|---|---|---|---|
Gender | ||||
 Female | 11 (47.83) | 3 | 8 | NS |
 Male | 12 (52.17) | 7 | 5 | |
Age (year) | ||||
 > 50.35 | 14 (60.87) | 7 | 7 | NS |
 ≤ 50.35 | 9 (39.13) | 3 | 6 | |
Grade | ||||
 WHO II | 6 (26.09) | 5 | 1 | 0.019* |
 WHO III | 5 (21.74) | 3 | 2 | |
 WHO IV | 12 (52.17) | 2 | 10 | |
Primary recurrent state | ||||
 Primary | 19 (0.83) | 8 | 11 | NS |
 Recurrent | 4 (0.17) | 2 | 2 |